Aurinia Pharmaceuticals (AUPH) EBITDA (2020 - 2026)
Aurinia Pharmaceuticals (AUPH) recorded EBITDA of $51.18 million in Q2 2026, up 105.1% from $24.95 million a year earlier and up 10.7% from the prior quarter.
Powered by 
Analysis
Aurinia Pharmaceuticals (AUPH) EBITDA (2020 - 2026) Analysis & Trends
On a TTM basis, Aurinia Pharmaceuticals' EBITDA came in at $170.13 million as of Jun 30, 2026, up 138.0% year-over-year; for FY2025, it was $124.36 million, up 742.7% from FY2024.
- Across earlier years, EBITDA came in at $14.76 million in FY2024, -$80.04 million in FY2023, -$108.76 million in FY2022 and -$175.87 million in FY2021.
- The Q2 2026 figure is the highest quarterly EBITDA in data going back to Q1 2020.
- Per Business Quant, the preceding three quarters came in at $46.24 million (Q1 2026), $38.1 million (Q4 2025) and $34.61 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Aurinia Pharmaceuticals | 2.20 Bn | 623.91 Mn | 76.67 Mn | 51.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 51.18 Mn |
| Mar 31, 2026 | 46.24 Mn |
| Dec 31, 2025 | 38.10 Mn |
| Sep 30, 2025 | 34.61 Mn |
| Jun 30, 2025 | 24.95 Mn |
| Mar 31, 2025 | 26.70 Mn |
| Dec 31, 2024 | 3.19 Mn |
| Sep 30, 2024 | 16.64 Mn |
| Jun 30, 2024 | 3.33 Mn |
| Mar 31, 2024 | -8.41 Mn |
| Dec 31, 2023 | -35.77 Mn |
| Sep 30, 2023 | -11.00 Mn |
| Jun 30, 2023 | -15.45 Mn |
| Mar 31, 2023 | -28.87 Mn |
| Dec 31, 2022 | -29.99 Mn |
| Sep 30, 2022 | -8.39 Mn |
| Jun 30, 2022 | -35.30 Mn |
| Mar 31, 2022 | -37.20 Mn |
| Dec 31, 2021 | -33.57 Mn |
| Sep 30, 2021 | -49.64 Mn |
API Access
Aurinia Pharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=AUPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "AUPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=AUPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();